194 related articles for article (PubMed ID: 8643355)
21. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS; Madore SJ; Malim MH; Cullen BR
Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
[TBL] [Abstract][Full Text] [Related]
22. A dynamic in vivo view of the HIV-I Rev-RRE interaction.
Charpentier B; Stutz F; Rosbash M
J Mol Biol; 1997 Mar; 266(5):950-62. PubMed ID: 9086273
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of HIV-1 Rev-RRE interaction by diphenylfuran derivatives.
Ratmeyer L; Zapp ML; Green MR; Vinayak R; Kumar A; Boykin DW; Wilson WD
Biochemistry; 1996 Oct; 35(42):13689-96. PubMed ID: 8885849
[TBL] [Abstract][Full Text] [Related]
24. Altering the context of an RNA bulge switches the binding specificities of two viral Tat proteins.
Smith CA; Crotty S; Harada Y; Frankel AD
Biochemistry; 1998 Jul; 37(30):10808-14. PubMed ID: 9692971
[TBL] [Abstract][Full Text] [Related]
25. RNA recognition and regulation of HIV-1 gene expression by viral factor Tat.
Naryshkin NA; Gait MJ; Ivanovskaya MG
Biochemistry (Mosc); 1998 May; 63(5):489-503. PubMed ID: 9632883
[TBL] [Abstract][Full Text] [Related]
26. HIV-1 regulatory protein tat induces RNA binding proteins in central nervous system cells that associate with the viral trans-acting-response regulatory motif.
Kundu M; Ansari SA; Chepenik LG; Pomerantz RJ; Khalili K; Rappaport J; Amini S
J Hum Virol; 1999; 2(2):72-80. PubMed ID: 10225209
[TBL] [Abstract][Full Text] [Related]
27. Interaction of HIV Tat model peptides with tRNA and 5S rRNA.
Giel-Pietraszuk M; Barciszewska MZ; Mucha P; Rekowski P; Kupryszewski G; Barciszewski J
Acta Biochim Pol; 1997; 44(3):591-600. PubMed ID: 9511968
[TBL] [Abstract][Full Text] [Related]
28. Sequence requirements for Rev multimerization in vivo.
Madore SJ; Tiley LS; Malim MH; Cullen BR
Virology; 1994 Jul; 202(1):186-94. PubMed ID: 7516596
[TBL] [Abstract][Full Text] [Related]
29. Binding kinetics and bioassay of RRE mRNA fragments to a peptide containing the recognition domain of HIV-1 Rev.
West ML; Ramsdale TE
Biomed Pept Proteins Nucleic Acids; 1996-1997; 2(3):85-8. PubMed ID: 9575345
[TBL] [Abstract][Full Text] [Related]
30. In silico mutagenesis of RNA splicing in HIV-1.
Kim H; Yin J
Biotechnol Bioeng; 2005 Sep; 91(7):877-93. PubMed ID: 15937951
[TBL] [Abstract][Full Text] [Related]
31. Long-term protection against HIV-1 infection conferred by tat or rev antisense RNA was affected by the design of the retroviral vector.
Peng H; Callison D; Li P; Burrell C
Virology; 1996 Jun; 220(2):377-89. PubMed ID: 8661389
[TBL] [Abstract][Full Text] [Related]
32. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
Long KS; Crothers DM
Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
[TBL] [Abstract][Full Text] [Related]
33. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
Huq I; Rana TM
Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
[TBL] [Abstract][Full Text] [Related]
34. Modulation of HTLV-I gene expression by HIV-1 Rev through an alternative RxRE-independent pathway mediated by the RU5 portion of the 5'-LTR.
Kubota S; Furuta RA; Hatanaka M; Pomerantz RJ
Biochem Biophys Res Commun; 1998 Feb; 243(1):79-85. PubMed ID: 9473483
[TBL] [Abstract][Full Text] [Related]
35. Structure-based design of a dimeric RNA-peptide complex.
Campisi DM; Calabro V; Frankel AD
EMBO J; 2001 Jan; 20(1-2):178-86. PubMed ID: 11226168
[TBL] [Abstract][Full Text] [Related]
36. Combination gene therapy: synergistic inhibition of human immunodeficiency virus Tat and Rev functions by a single RNA molecule.
Lisziewicz J; Zeng G; Gratas C; Weinstein JN; Lori F
Hum Gene Ther; 2000 Apr; 11(6):807-15. PubMed ID: 10779158
[TBL] [Abstract][Full Text] [Related]
37. Incorporation of an artificial protease and nuclease at the HIV-1 Tat binding site of trans-activation responsive RNA.
Shah K; Neenhold H; Wang Z; Rana TM
Bioconjug Chem; 1996; 7(3):283-9. PubMed ID: 8816949
[TBL] [Abstract][Full Text] [Related]
38. The HIV-1 Tat transactivator protein: a therapeutic target?
Fulcher AJ; Jans DA
IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003
[TBL] [Abstract][Full Text] [Related]
39. Bovine immunodeficiency virus tat gene: cloning of two distinct cDNAs and identification, characterization, and immunolocalization of the tat gene products.
Fong SE; Greenwood JD; Williamson JC; Derse D; Pallansch LA; Copeland T; Rasmussen L; Mentzer A; Nagashima K; Tobin G; Gonda MA
Virology; 1997 Jul; 233(2):339-57. PubMed ID: 9217057
[TBL] [Abstract][Full Text] [Related]
40. Influence of the small leader exons 2 and 3 on human immunodeficiency virus type 1 gene expression.
Krummheuer J; Lenz C; Kammler S; Scheid A; Schaal H
Virology; 2001 Aug; 286(2):276-89. PubMed ID: 11485396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
